Skip to main content
Clinical Trials/NCT02594631
NCT02594631
Unknown
Phase 4

Shock Wave Lithotripsy Versus Visual Cystolitholapaxy in The Management of Patients Presenting With Calcular Acute Urinary Retention: A Randomized Controlled Trial.

Mansoura University1 site in 1 country100 target enrollmentMarch 2015
ConditionsUrinary Calculi

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Urinary Calculi
Sponsor
Mansoura University
Enrollment
100
Locations
1
Primary Endpoint
Stone free rate
Last Updated
10 years ago

Overview

Brief Summary

The aim of the study is to compare the safety and efficacy of ESWL and visual cystolitholapaxy in management of calcular acute urine retention.

Detailed Description

Patients who present with acute urinary retention due to stone in the urethra or urinary bladder will be randomly assigned to receive treatment either by extracorporeal shock wave lithotripsy or by endoscopic visual cystolitholapaxy where patients and stone characteristics will be recorded and the outcome including the intraoperative and postoperative complications and the stone free rate will be also evaluated

Registry
clinicaltrials.gov
Start Date
March 2015
End Date
April 2016
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mohamed Ali

Resident in Urology, Urology and Nephrology Center, Mansoura University

Mansoura University

Eligibility Criteria

Inclusion Criteria

  • Adult male patients presenting with acute urinary retention due to urethral or urinary bladder stones.
  • with a stone size not more than 2 centimeters in greatest diameter.
  • No more than 2 stones.

Exclusion Criteria

  • Bladder cancer.
  • Bladder replacement of any type.
  • Infravesical obstruction, due to marked benign prostatic hyperplasia, prostate cancer, stricture urethra or external urethral meatal stenosis.

Outcomes

Primary Outcomes

Stone free rate

Time Frame: 1 week

evaluation of stone free rate after the assigned intevention

Secondary Outcomes

  • Adverse events after the assigned intervention(1 month)

Study Sites (1)

Loading locations...

Similar Trials